Search Results 911-920 of 18154 for monoclonal antibody

1. Monoclonal gammopathy of undetermined significance (MGUS) - Doctors and departments - Mayo Clinic

   A condition of blood plasma that produces altered antibodies that increase the risk of blood cancers and other conditions.

2. A Phase II, Multicenter Study Of The EZH2 Inhibitor Tazemetostat In Adult Subjects With INI1-Negative Tumors Or Relapsed/Refractory Synovial Sarcoma - Mayo Clinic

   Monoclonal antibody (ies). At least 28 days since the last dose of monoclonal antibody prior to first dose of tazemetostat. Immunotherapy (e.g., tumor vaccine).

3. Publications - Sarosh R. Irani, B.M., B.Ch., D.Phil. - Mayo Clinic

   Peripherally-derived LGI1-reactive monoclonal antibodies cause epileptic seizures in vivo. ... Magnetic Resonance Imaging Characteristics of LGI1-Antibody and ...

4. Fallopian Tube Cancer Clinical Trials - Mayo Clinic Research

   Monoclonal antibodies, such as bevacizumab, may interfere with the ability of tumor cells to grow and spread. Using an Avatar, a living tumor sample with ...

5. Daratumumab for Treatment of Proliferative Glomerulonephritis With Monoclonal Immune Deposits (PGNMID) - Mayo Clinic

   ... monoclonal immunoglobulin deposits (PGNMID) by assessing improvement in proteinuria at 12 months. ... antibodies to hepatitis B core antigen [anti-HBc] and/or ...

6. Publications - M Mateo Paz Soldan, M.D.,PH.D. - Mayo Clinic

   Human monoclonal IgM antibody promotes CNS myelin repair independent of Fc function. Brain Pathol. 2003 Oct; 13 (4):608-16. View PubMed; Paz Soldan MM ...

7. Medication overuse headaches - Diagnosis and treatment - Mayo Clinic

   If you have a history of migraine, your healthcare professional might suggest a CGRP monoclonal antibody such as erenumab (Aimovig), galcanezumab (Emgality) ...

8. COVID-19 Antibody Testing Clinical Trials - Mayo Clinic Research

   ... antibody detectable targets on cancer cells (cancer vaccines or antibody guided therapeutics). In this approach, we isolate and affinity-column immobilize ...

9. Mayo Clinic Q & A - Dr. Gregory Poland -Respiratory viruses

   And the other is you mentioned monoclonal antibodies not to being effective. Are we still using them? Dr. Greg Poland 09:14. We are because there's some ...

10. A Study of AZD2936 Anti-TIGIT/Anti-PD-1 Bispecific Antibody in Participants With Advanced or Metastatic NSCLC - Mayo Clinic

    This is a Phase I/II study designed to evaluate if experimental anti-TIGIT/anti-PD-1 bispecific antibody rilvegostomig (AZD2936) is safe, tolerable and ...